K-numberK253534
Device namePivot Insulin Delivery System
ApplicantModular Medical
Product codeLZG
Device classClass II
Decision dateApr 8, 2026
DecisionSubstantially Equivalent
Regulation880.5725
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Pivot Insulin Delivery System is a programmable insulin infusion pump designed for subcutaneous delivery of insulin at set and variable basal and bolus rates for adults 18 years and older with diabetes mellitus requiring insulin therapy. It consists of a reusable microprocessor-controlled pump, a disposable 3.0mL insulin cartridge with integrated battery, a disposable integrated infusion set with built-in cannula and adhesive pad, a reusable inserter device, and a smartphone application for configuration.

Technological characteristics

The Pivot System retains the identical motor-driven, microprocessor-controlled multi-piston delivery mechanism and operating principle as its predicate (MODD1 System K240158). The main technological differences are integration of the infusion set and adhesive pad into a single disposable component, introduction of a reusable Pivot Inserter replacing the external Orbit Inserter, a revised cartridge connection interface for direct coupling, and updated packaging. The pump, software, control logic, basal rate range (0.5-4 units/hour), bolus range (2-20 units), and suspension capability remain identical.

Test standards cited

Not stated in this summary.

Substantial equivalence argument

Modular Medical argues substantial equivalence based on identical indications for use, retention of the same fundamental operating principle and control logic, and comprehensive verification and validation testing demonstrating that design modifications do not raise different safety or effectiveness questions. Testing included biocompatibility, sterilization validation, insulin compatibility, delivery accuracy, occlusion detection, adhesive performance, inserter reliability, and human factors validation—all meeting predefined acceptance criteria. The modifications are limited to component integration and interface changes that do not alter the fundamental scientific technology or intended use.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →